Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:793-798
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000154685.54766.2d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/4/793    most recent
01.HYP.0000154685.54766.2dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, S. T.
Right arrow Articles by de Andrade, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, S. T.
Right arrow Articles by de Andrade, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Diseases
*High Blood Pressure
Related Collections
Right arrow Clinical genetics
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Genomics
Right arrow Genetics of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Epidemiology

(Hypertension. 2005;45:793.)
© 2005 American Heart Association, Inc.


Original Articles

Genomic Susceptibility Loci for Brain Atrophy in Hypertensive Sibships From the GENOA Study

Stephen T. Turner; Myriam Fornage; Clifford R. Jack, Jr; Thomas H. Mosley; Sharon L. R. Kardia; Eric Boerwinkle; Mariza de Andrade

From the Division of Nephrology and Hypertension (S.T.T.), Department of Internal Medicine; the Division of Biostatistics (M.d.), Department of Health Sciences Research; and the Department of Diagnostic Radiology (C.R.J.), Mayo Clinic and Foundation, Rochester, Minn; the Division of Geriatrics (T.H.M.), Department of Medicine, University of Mississippi Medical Center, Jackson; the Department of Epidemiology (S.L.R.K.), University of Michigan, Ann Arbor; and the Human Genetics Center and Institute of Molecular Medicine (M.F., E.B.), University of Texas-Houston Health Science Center, Houston.

Correspondence to Stephen T. Turner, MD, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail turner.stephen{at}mayo.edu

We measured 366 microsatellite markers genome-wide to search for loci contributing to subcortical white matter ischemic damage (leukoariosis) and brain atrophy in 488 non-Hispanic white subjects (193 men, 295 women; mean age±SD=64.1±7.7 years; 79% hypertensive) from 223 sibships recruited through ≥2 members with essential hypertension diagnosed before age 60. Leukoariosis was quantitated by magnetic resonance imaging (MRI), brain atrophy by the difference between intracranial and brain volumes, and calculated mean arterial pressure and pulse pressure provided measures of steady-state level and pulsatile components of blood pressure. After adjustment for sex and age, variance components models estimated significant heritability of leukoariosis (0.72), brain atrophy (0.52), mean arterial pressure (0.084), and pulse pressure (0.294) (P<0.0001 for each trait). Univariate maximum logarithm of odds scores (MLS) were observed for leukoariosis on chromosome 5 (MLS=1.91; P=0.00150); for brain atrophy on 1q and 17p (MLS=2.76, P=0.00018); for mean arterial pressure on 11p (MLS=1.57; P=0.00354); and for pulse pressure on 11p (MLS=3.02; P=0.00070). Bivariate linkage analyses provided evidence of loci with pleiotropic effects on brain atrophy and pulse pressure on chromosomes 11p (MLS = 5.07 at 16 cM; P=0.00001) and 16q (MLS of 4.56 at 124 cM; P=0.00003). These results demonstrate usefulness of multivariate linkage analyses to detect loci with pleiotropic effects on genetically correlated traits and suggest overlap between the genes influencing blood pressure and those contributing to brain atrophy.


Key Words: blood pressure • brain • genetics




This article has been cited by other articles:


Home page
StrokeHome page
L. Paternoster, W. Chen, and C. L.M. Sudlow
Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects * Supplemental References
Stroke, June 1, 2009; 40(6): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Lacolley, P. Challande, M. Osborne-Pellegrin, and V. Regnault
Genetics and pathophysiology of arterial stiffness
Cardiovasc Res, March 1, 2009; 81(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Zintzaras, G. Kitsios, D. Kent, N. J. Camp, L. Atwood, P. N. Hopkins, and S. C. Hunt
Genome-Wide Scans Meta-Analysis for Pulse Pressure
Hypertension, September 1, 2007; 50(3): 557 - 564.
[Abstract] [Full Text] [PDF]